Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.
Daraxonrasib has been approved for metastatic pancreatic cancer. We saw that coming. The RAS-agnostic indication? That was a bit of a surprise.
⬇️ We spoke with Nicholas Hornstein, MD, PhD (@GIMedOnc), about it!
#pancsm# #oncology# #cancer#